Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations
- PMID: 28419384
- PMCID: PMC5939871
- DOI: 10.1093/pm/pnx038
Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations
Abstract
Objective: To characterize the risk factors associated with overdose or serious opioid-induced respiratory depression (OIRD) among medical users of prescription opioids in a commercially insured population (CIP) and to compare risk factor profiles between the CIP and Veterans Health Administration (VHA) population.
Subjects and methods: Analysis of data from 18,365,497 patients in the IMS PharMetrics Plus health plan claims database (CIP) who were dispensed a prescription opioid in 2009 to 2013. Baseline factors associated with an event of serious OIRD among 7,234 cases and 28,932 controls were identified using multivariable logistic regression. The CIP risk factor profile was compared with that from a corresponding logistic regression among 817 VHA cases and 8,170 controls in 2010 to 2012.
Results: The strongest associations with serious OIRD in CIP were diagnosed substance use disorder (odds ratio [OR] = 10.20, 95% confidence interval [CI] = 9.06-11.40) and depression (OR = 3.12, 95% CI = 2.84-3.42). Other strongly associated factors included other mental health disorders; impaired liver, renal, vascular, and pulmonary function; prescribed fentanyl, methadone, and morphine; higher daily opioid doses; and concurrent psychoactive medications. These risk factors, except depression, vascular disease, and specific opioids, largely aligned with VHA despite CIP being substantially younger, including more females and less chronic disease, and having greater prescribing prevalence of higher daily opioid doses, specific opioids, and most selected nonopioids.
Conclusions: Risk factor profiles for serious OIRD among US medical users of prescription opioids with private or public health insurance were largely concordant despite substantial differences between the populations in demographics, clinical conditions, health care delivery systems, and clinical practices.
Keywords: Opioids; Overdose; Respiratory Depression; Risk Factors.
© 2017 American Academy of Pain Medicine.
Similar articles
-
Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database.Pain Med. 2018 Jan 1;19(1):68-78. doi: 10.1093/pm/pnx009. Pain Med. 2018. PMID: 28340046 Free PMC article.
-
Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.Pain Med. 2014 Nov;15(11):1911-29. doi: 10.1111/pme.12480. Epub 2014 Jun 14. Pain Med. 2014. PMID: 24931395
-
Evaluating the Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Patients with Cancer.J Pain Palliat Care Pharmacother. 2024 Jun;38(2):131-137. doi: 10.1080/15360288.2024.2348620. Epub 2024 May 9. J Pain Palliat Care Pharmacother. 2024. PMID: 38722684
-
Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients.Pain Physician. 2013 Mar-Apr;16(2):E85-94. Pain Physician. 2013. PMID: 23511694 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
-
High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.J Am Geriatr Soc. 2023 Jan;71(1):98-108. doi: 10.1111/jgs.18102. Epub 2022 Oct 26. J Am Geriatr Soc. 2023. PMID: 36289563 Free PMC article.
-
Validation of an administrative claims coding algorithm for serious opioid overdose: A medical chart review.Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1422-1428. doi: 10.1002/pds.4886. Epub 2019 Sep 4. Pharmacoepidemiol Drug Saf. 2019. PMID: 31483548 Free PMC article.
-
An integrated LSTM-HeteroRGNN model for interpretable opioid overdose risk prediction.Artif Intell Med. 2023 Jan;135:102439. doi: 10.1016/j.artmed.2022.102439. Epub 2022 Nov 3. Artif Intell Med. 2023. PMID: 36628797 Free PMC article.
-
A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults.Clin Transl Sci. 2023 Nov;16(11):2331-2344. doi: 10.1111/cts.13634. Epub 2023 Sep 19. Clin Transl Sci. 2023. PMID: 37705211 Free PMC article.
-
A systematic analysis and data mining of opioid-related adverse events submitted to the FAERS database.Exp Biol Med (Maywood). 2023 Nov;248(21):1944-1951. doi: 10.1177/15353702231211860. Epub 2023 Dec 30. Exp Biol Med (Maywood). 2023. PMID: 38158803 Free PMC article.
References
-
- Frenk SM, Porter KS, Paulozzi LJ.. Prescription opioid analgesic use among adults: United States, 1999–2012. NCHS Data Brief 2015;189:1–8. - PubMed
-
- Kolodny A, Courtwright DT, Hwang CS, et al.The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annu Rev Public Health 2015;361:559–74. - PubMed
-
- Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press; 2011. - PubMed
-
- Paulozzi L, Jones C, Mack KA, Rudd R.. Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011;6043:1487–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases